With over $410 million in financing; to advance portfolio of next-gen oral and injectable treatments with first- or ...

Excipient GMP certification validates the company's quality systems and process controls to support the cell and gene therapy ...

Enhancing its peptide synthesis capabilities to meet increasing demand from its global partners for efficient and scalable ...